Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-12-04
2007-12-04
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S263800
Reexamination Certificate
active
11186519
ABSTRACT:
Compounds of this invention are non-peptide, reversible inhibitors of type 2 methionine aminopeptidase, useful in treating conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, atherosclerotic neovascularization, psoriasis, ocular neovascularization and obesity.
REFERENCES:
patent: 4537899 (1985-08-01), Horvath et al.
patent: 4670448 (1987-06-01), Clitherow et al.
patent: 5760246 (1998-06-01), Biller et al.
patent: 5883110 (1999-03-01), Tang et al.
patent: 2004/0004116 (2004-01-01), Hatanaka et al.
patent: 2004/0116490 (2004-06-01), Marino, Jr. et al.
patent: 2004/0116495 (2004-06-01), Marino, Jr. et al.
patent: 2005/0143578 (2005-06-01), Kallander et al.
patent: 2005/0222212 (2005-10-01), Marino et al.
patent: 2006/0247280 (2006-11-01), Marino, Jr. et al.
patent: 4142366 (1993-06-01), None
patent: 4424787 (1996-01-01), None
patent: 4425144 (1996-01-01), None
patent: 19922443 (2000-11-01), None
patent: WO93/20066 (1993-10-01), None
patent: WO98/56372 (1998-12-01), None
patent: WO 00/67734 (2000-11-01), None
patent: WO 01/36404 (2001-05-01), None
patent: WO 01/53274 (2001-07-01), None
patent: WO 01/53331 (2001-07-01), None
patent: WO 01/78723 (2001-10-01), None
patent: WO 02/05804 (2002-01-01), None
patent: WO 02/081415 (2002-10-01), None
patent: WO 03/051906 (2003-06-01), None
Son et al. Bioorganic & Medicinal Chemistry (2002), vol. 10, No. 1, pp. 185-188.
Lala et al. Cancer and Metastasis Reviews (1998), vol. 17, No. 1, pp. 91-106.
Fromm et al., Splitting of Disulfides. Synthesis of Triazoles, (1924), 812757; Journal; JLACBF; Justus Liebigs Ann. Chem.; 437, pp. 106-124 (original with translation).
Patent Abstracts of Japan, 013(423) (C-638) Sep. 20, 1989 & JP 01 160972 (Tsumura & Co.), Jun. 23, 1989.
Azev et al., “Transformation of Azido Derivatives of S-Triazine into 1,2,4-Triazolylaminotetrazoles”,Mendeleev Communications, 2: 49-50 (1993).
Trinka et al., “The Arylation of 5-Amino-3-Methylthio-1H-1,2,4-Triazole with Activated Aryl Chlorides”,Journal of Heterocyclic Chemistry, 32(4): 1359-1371 (1995).
Tolstyakov et al., “Synthesis of Novel Derivatives of 3(5)-Alkylsulfonyl-1,2,4-Trizoles”.Russian Journal of General Chemistry, Consultants Bureau, US, 70(9): 1458-1465 (2000).
Son et al. Bioorganic & Medicinal Chemistry (2002), vol. 10(1), pp. 185-188.
Lala et al. Cancer and Metastasis Reviews (1998), vol. 17(1), pp. 91-106.
Selvakumar et al., “High Expression of Methionine Aminopeptidase 2 in Human Colorectal Adenocarcinomas”,Clinical Cancer Res., 10: 2771-2775 (2004).
Wang et al., “Tumor Suppression by a Rationally Designed Reversible Inhibitor of Methionine Aminopeptidase-2”.Cancer Res., 63: 7861-7869 (2003).
Kallander et al.J. Med. Chem., 48: 5644-5647 (2005).
Yang et al.Biochemistry, 40: 10645-10654 (2001).
Marino, Jr. Joseph P.
Thompson Scott K.
Veber Daniel Frank
Anderson Rebecca
Kinzig Charles M.
McCarthy Mary E.
Sieburth Kathryn L.
SmithKline Beecham Corporation
LandOfFree
1,2,4-triazole derivatives, compositions, process of making... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,2,4-triazole derivatives, compositions, process of making..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,2,4-triazole derivatives, compositions, process of making... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3853245